United States · Series A startup

Who invested in Curvo Labs

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$2.0Mraised across 1 round since 2019, from 1 source

Latest round
Series A, $2.0MOct 2019
Investors
2
See who backed them

The rounds

  1. Oct 2019
    Series A$2.0M

    Reported by FinSMEsSEC filing: $2.0M sold, first sale Sept 2019

Founders and team

From the SEC filings it signed: 1 on the team.

  • Andrew PerryExecutive Officer, Directori

On the board, as filediKent ParkerSteven Suhrheinrich

Everyone who backed them

Elevate VenturesVC firm1round
Snake Run CapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list Curvo Labs as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Elevate VenturesAngel networkPer its own site
Hughes & CompanyPrivate equityPer its own site

Quick answers about Curvo Labs

Who invested in Curvo Labs?

Curvo Labs's investors include Elevate Ventures and Snake Run Capital.

How much has Curvo Labs raised?

Curvo Labs has raised $2.0M across 1 round since 2019.

When did Curvo Labs last raise?

Curvo Labs's most recent round was a Series A of $2.0M in Oct 2019.

What was Curvo Labs's biggest round?

Its most recent round, $2.0M in Oct 2019, is also its largest on record.

Who backed Curvo Labs first?

Curvo Labs's first round on record, in Oct 2019, was backed by Elevate Ventures and Snake Run Capital.

What stage is Curvo Labs at?

Curvo Labs's latest named round is a Series A, in Oct 2019.

Where is Curvo Labs based?

Curvo Labs is based in the United States.

Companies like Curvo Labs

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.